Arcutis Biotherapeutics Inc Sustainability Reports
A commercial-stage biopharmaceutical company developing and commercializing topical treatments for immune-mediated dermatological diseases, such as psoriasis and atopic dermatitis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00QN8K4P1
7 reports from 2021 to 2025
